Synapse - Matthew Matasar

Results (290)

Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)

Meeting Abstract

Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan

Meeting Abstract

Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; more...
Blood (2012)

Fulltext@MSK | Save

Histiocytic sarcoma of the central nervous system: A case report

Meeting Abstract

Curry, R.; Joyce, J.; Rosenblum, M.; Jaffe, E.; Matasar, M.; Lin, O.; Fisher, R.; Omuro, A.
Neuro-Oncology (2012)

Fulltext@MSK | Save

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

Journal Article

Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
Blood (2012)

Fulltext@MSK | Save

Risk of nausea and vomiting in patients with lymphoma undergoing high dose therapy with autologous stem cell rescue

Meeting Abstract

Puto, M.; Adel, N.; Riedel, E.; Giralt, S. A.; Matasar, M. J.
Biology of Blood and Marrow Transplantation (2012)

Fulltext@MSK | Save

Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification

Journal Article

Matasar, M. J.; Shi, W.; Silberstein, J.; Lin, O.; Busam, K. J.; Teruya-Feldstein, J.; Filippa, D. A.; Zelenetz, A. D.; Noy, A.
Annals of Oncology (2012)

Fulltext@MSK | Save

Peripheral T-cell lymphomas

Book Section

Horwitz, S. M.; Matasar, M. J.
In O'Brien, S. M.; Vose, J. M.; Kantarjian, H. M. (Eds.) Management of Hematologic Malignancies (2011)

Fulltext@MSK | Save

A phase II study of ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory aggressive B-cell lymphoma prior to autologous stem cell transplantation (ASCT)

Meeting Abstract

Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
Blood (2011)

Fulltext@MSK | Save

Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET